Filing Details

Accession Number:
0000950170-25-098542
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-24 20:32:18
Reporting Period:
2025-07-22
Filing Date:
2025-07-24
Accepted Time:
2025-07-24 20:32:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1794546 Carlsmed Inc. CARL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1416947 Kevin Sidow C/O Carlsmed, Inc.
1800 Aston Ave., Suite 100
Carlsbad CA 92008
No No No No
Transaction Summary
Purchased: 13,333 shares Avg. Price: $15.00 Total Value: $199,995.00
Number of Shares After Transactions: 59,566 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-07-22 17,333 $0.00 17,333 No 4 A Direct
Common Stock Acquisiton 2025-07-24 28,900 $0.00 28,900 No 4 M Direct
Common Stock Acquisiton 2025-07-24 13,333 $15.00 59,566 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2025-07-24 28,900 $0.00 28,900 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.
  2. Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.
  3. These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.
  4. Includes 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.
  5. Includes (i) 17,333 unvested RSUs convertible into approximately 17,333 shares of the Issuer's common stock, (ii) 28,900 shares of common stock issued to Reporting Person upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering, and (iii) 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share.